Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance

Cancer

Volumn 115, Issue 9, 2009, Pages 1840-1848

  Dillman, Robert O ^a   Aaron, Kenneth ^a   Heinemann, F Scott ^a   Mcciure, Stephanie E ^a  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

Author keywords

Colon cancer; Colorectal fellowship training; Lymph nodes; Pathology procedures

Indexed keywords

ADULT; AGED; ANATOMY; ARTICLE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLORECTAL SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; HOSPITAL; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; SURGEON; SURGICAL TRAINING;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; GENERAL SURGERY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES;

EID: 65649125258     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24185     Document Type: Article

References (33)

1. Andre T. Bonik C. Mounedji-Boudiaf LM, et al. Oxalipladn. fluorouracil. and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2243-2251. (Pubitemid 38702845)
2. Gill S. Loprinzi C. L. Sargent D. J. et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer; who benefits and by how much? J Clin Oncol. 2004;22:1797-1806. (Pubitemid 41095169)
3. Haller D. G. Catalano P. J. Macdonald J. S. et al. Phase III study of fluorouracil. leucovorin. and levamisole in highrisk stage II and II colon cancer: final report of intergroup 0089. J Clin Oncol. 2005;23;8671-8678.
4. Twelves C. Wong A. Nowacki M. P. et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005;352:2696-2704. (Pubitemid 41007824)
5. Kuebler J. P. Wieand H. S. O'Connell M. J. et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and II coon cancer: results from NSABP C-07. J Clin Oncol. 2007;25: 2198-2204. (Pubitemid 46954643)
6. Feig B. W. Curley S. Lucci A. et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2002;182:707-712.
7. Redston M. Compton C. C. Miedema B. W. et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.J Clin Oncol. 2006;24:878-883. (Pubitemid 46638839)
8. Bilchik A. J. Hoon D. S. Saha S. et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg. 2007;246:568-575. (Pubitemid 47480600)
9. Stojadinovic A. Nissan A. Protic M. et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military' Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 007;245:846-857. (Pubitemid 46809284)
10. Le Voyer T. E. Sigurdson E. R. Hanlon A. L. et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed; a secondary survey of intergroup trial INT- 0089. J Clin Oncol. 2003;21:2912-2919. (Pubitemid 46621841)
11. Prandi M. Lionetto R. Bini A. et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-463. (Pubitemid 34258343)
12. Swanson R. S. Compton C. D. C. Stewart A. K. Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
13. Bui L. Rempel E. Reeson D. Lymph node counts, rates of positive lymph nodes. and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93:439-445. (Pubitemid 44651266)
14. Cserni G. Vinh-Hung V. Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol. 2002;81:63-69.
15. Carloss H. Huang B. Cohen A. et al. The impact of number of lymph odes removed on 5-year survival in stage II colon and rectal cancer. J Ky Med Assoc. 2006;102:345-347.
16. Caplin S. Cerottini J. P. Bosman F. T. et al. For patients with Dukes' B (TNM stage II) colorectal carcinoma. examination of 6 or fewer lymph nodes is related to poor prognosis, Cancer. 1998;83:666-672. (Pubitemid 28387688)
17. Law C. H. Wright F. C. Rapanos T. et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84:120-126. (Pubitemid 37363153)
18. Cianchi F. Palomba A. Boddi V. et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26:384-389. (Pubitemid 36920420)
19. Yashimatsu K. Ishibashi K. Umehara A. et al. How many lymph nodes should be examined in Dukes' B colorectal cancer. Hepatogastroenterology. 2005;52; 1703-1706.
20. Gumus M. Yumuk P. F. Atalay G. et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005;91:168-172. (Pubitemid 40705091)
21. Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology. 2004;51:1689-1693.
22. Goldstein N. S. Lymph node recoveries from 2427 pT3 coloreet al. resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-189. (Pubitemid 34127497)
23. Sarli L. Bader G. lusco D. et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eurj Cancer. 2005;41:272-279. (Pubitemid 40126960)
24. Wong J. H. Bowles B. J. Bueno R. Shimizu D. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum. 2002;45:1341-1348. (Pubitemid 35176044)
25. Ratto C. Sofo L. Ippoliti M. et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999;42:143-154. (Pubitemid 29085149)
26. Jestin P. Pahlman L. Glimelius B. Gunnarsson U. Cancer staging and survival In colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer. 2005;41:2071-2078. (Pubitemid 41337948)
27. Scott K. W. Grace R. H. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165-1167. (Pubitemid 19284443)
28. Institute of Medicine of the National Academies. Performance Measurement: Accelerating Improvement. Washington, DC: National Academies Press; 2006. (Pubitemid 43928652)
29. Dillman R. O. Chico S. D. Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks.J Oncol Prac. 2005; 1:84-92.
30. Schrag D. Cramer L. D. Bach P. B. Cohen A. M. Warren J. L. Begg C. B. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000;284: 3028-3035. (Pubitemid 32014740)
31. Abcarian H. Operative treatment of colorectal cancer. Cancer. 1992;70:1350-1354.
32. Nelson H. Petrelli N. Carlin A. et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2000; 93:583-596.
33. Chang G. J. Rodriguez-Bigas M. A. Skibber J. M. Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99:433-441. (Pubitemid 47073566)